Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients

Autor: Fleur van der Sijde, Willem A. Dik, Dana A. M. Mustafa, Eveline E. Vietsch, Marc G. Besselink, Reno Debets, Bas Groot Koerkamp, Brigitte C. M. Haberkorn, Marjolein Y. V. Homs, Quisette P. Janssen, Saskia A. C. Luelmo, Leonie J. M. Mekenkamp, Astrid A. M. Oostvogels, Marja A. W. Smits-te Nijenhuis, Johanna W. Wilmink, Casper H. J. van Eijck, the Dutch Pancreatic Cancer Group

Publikováno v: Frontiers in Immunology, Vol 13 (2022)

BackgroundBiomarkers predicting treatment response may be used to stratify patients with pancreatic ductal adenocarcinoma (PDAC) for available therapies. The aim of this study was to evaluate the association of circulating cytokines with FOLFIRINOX r

Externí odkaz: https://doaj.org/article/55155bc8478d42a488e7996f4f409527

The impact of cancer treatment on quality of life in patients with pancreatic and periampullary cancer

Autor: Willemieke P M Dijksterhuis, Marc G. Besselink, Marjolein Y.V. Homs, Martijn G.H. van Oijen, Johanna W. Wilmink, Lydia G. M. van der Geest, Jennifer M.J. Schreinemakers, Tara M. Mackay, Anouk E J Latenstein, Saskia A C Luelmo, Hanneke W. M. van Laarhoven, I. Quintus Molenaar, Hjalmar C. van Santvoort, Mirjam A. G. Sprangers, Casper H.J. van Eijck

Publikováno v: HPB, 24(4), 443-451. ELSEVIER SCI LTD
HPB, 24(4), 443-451. John Wiley and Sons Inc.
HPB, 24(4), 443-451. John Wiley & Sons Inc.

Background The impact of pancreatic and periampullary cancer treatment on health-related quality of life (HRQoL) is unclear. Methods This study merged data from the Netherlands Cancer Registry with EORTC QLQ-C30 and -PAN26 questionnaires at baseline

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fefe15709430d7033761dc2e259d5fc3
http://www.scopus.com/inward/record.url?scp=85116852979&partnerID=8YFLogxK

Overview and future perspectives on tumor-targeted positron emission tomography and fluorescence imaging of pancreatic cancer in the era of neoadjuvant therapy

Autor: Martijn A. van Dam, Floris A. Vuijk, Judith A. Stibbe, Ruben D. Houvast, Saskia A. C. Luelmo, Stijn Crobach, Shirin Shahbazi Feshtali, Lioe-Fee de Geus-Oei, Bert A. Bonsing, Cornelis F. M. Sier, Peter J. K. Kuppen, Rutger-Jan Swijnenburg, Albert D. Windhorst, Jacobus Burggraaf, Alexander L. Vahrmeijer, J. Sven D. Mieog

Publikováno v: Cancers
van Dam, M A, Vuijk, F A, Stibbe, J A, Houvast, R D, Luelmo, S A C, Crobach, S, Feshtali, S S, de Geus-Oei, L-F, Bonsing, B A, Sier, C F M, Kuppen, P J K, Swijnenburg, R-J, Windhorst, A D, Burggraaf, J, Vahrmeijer, A L & Mieog, J S D 2021, ' Overview and future perspectives on tumor-targeted positron emission tomography and fluorescence imaging of pancreatic cancer in the era of Neoadjuvant therapy ', Cancers, vol. 13, no. 23, 6088 . https://doi.org/10.3390/cancers13236088
Cancers 2021, 13(23), 6088
Cancers, 13(23). MDPI
Cancers, Vol 13, Iss 6088, p 6088 (2021)

Simple Summary Patients diagnosed with pancreatic cancer have a poor prognosis at time of diagnosis, with a 5-year survival rate of merely 10%. The only treatment with curative intent is surgical resection of the tumor and adjacent tumor-containing l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5afc2efc609a61550f24db65900e1535
https://hdl.handle.net/1887/3277531

Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX

Autor: Fleur van der Sijde, Leonie J. M. Mekenkamp, Quisette P. Janssen, Marjolein Y.V. Homs, Zakia Azmani, Johanna W. Wilmink, Wilfred F. J. van IJcken, Bert A. Bonsing, Saskia A C Luelmo, Bas Groot Koerkamp, Brigitte C M Haberkorn, Eveline E. Vietsch, Dana A M Mustafa, Jan Willem B. de Groot, Casper H.J. van Eijck, Marc G. Besselink, Martijn P. Lolkema, Ron H.N. van Schaik

Publikováno v: Therapeutic advances in medical oncology, 13. SAGE Publications Inc.
Therapeutic Advances in Medical Oncology, 13, 1-14. SAGE PUBLICATIONS LTD
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, 13. SAGE Publishing

Background:Biomarkers predicting treatment response may be used to stratify pancreatic ductal adenocarcinoma (PDAC) patients for therapy. The aim of this study was to identify circulating tumor DNA (ctDNA) mutations that associate with tumor progress

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ef1aea0e11d599bac06eea43400b053
https://doi.org/10.1177/17588359211033704

The self-perceived palliative care barriers and educational needs of clinicians working in hospital primary care teams and referral patterns: lessons learned from a single-center survey and cohort study

Autor: Lotte van der Stap, Carla C M Juffermans, Yvette M. van der Linden, Ellen J M de Nijs, Marleen Oomes, Saskia A C Luelmo, Willeke M Ravensbergen, Nanda Horeweg

Publikováno v: Annals of Palliative Medicine, 10(3), 2620-2637. AME PUBL CO
Annals of Palliative Medicine, 10(3), 2620-2637. AME Publishing
Annals of palliative medicine

Background: Within the generalist-plus-specialist palliative care model, palliative care is mainly provided by nurses and physicians of hospital primary care teams. Palliative care consultation teams (PCCTs) support these clinicians in adequately car

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba6d6a4bbe6d3c9d88a378dc130a2849
http://hdl.handle.net/1887/3278815